Literature DB >> 26740626

Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.

Maoqing Dong1, Polo C-H Lam2, Andrew Orry2, Patrick M Sexton3, Arthur Christopoulos3, Ruben Abagyan4, Laurence J Miller5.   

Abstract

Amino-terminal regions of secretin-family peptides contain key determinants for biological activity and binding specificity, although the nature of interactions with receptors is unclear. A helix N-capping motif within this region has been postulated to directly contribute to agonist activity while also stabilizing formation of a helix extending toward the peptide carboxyl terminus and docking within the receptor amino terminus. We used cysteine trapping to systematically explore spatial approximations between cysteines replacing each residue in this motif of secretin (sec), Phe(6), Thr(7), and Leu(10), and cysteines incorporated into the extracellular face of the receptor. Each peptide was a full agonist for cAMP, but had a lower binding affinity than natural hormone. These bound to COS cells expressing 61 receptor constructs incorporating cysteines in every position along each extracellular loop (ECL) and adjacent parts of transmembrane (TM) segments. Patterns of covalent labeling were distinct for each probe, with Cys(6)-sec labeling multiple residues in the carboxyl-terminal half of ECL2 and throughout ECL3, Cys(7)-sec predominantly labeling only single residues in the carboxyl-terminal end of ECL2 and the amino-terminal end of ECL3, and Cys(10)-sec not efficiently labeling any of these residues. These spatial constraints were used to refine our model of secretin bound to its receptor, now bringing ECL3 above the amino terminus of the ligand and revealing possible charge-charge interactions between this part of secretin and receptor residues in TM5, TM6, ECL2, and ECL3, which can orient and stabilize the peptide-receptor complex. This was validated by testing predicted approximations by mutagenesis and residue-residue complementation studies.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  G protein-coupled receptor (GPCR); cell surface receptor; cyclic AMP (cAMP); gel electrophoresis; ligand-binding protein; membrane protein; molecular modeling; mutagenesis; peptides

Mesh:

Substances:

Year:  2016        PMID: 26740626      PMCID: PMC4777851          DOI: 10.1074/jbc.M115.706010

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Spatial approximation between the amino terminus of a peptide agonist and the top of the sixth transmembrane segment of the secretin receptor.

Authors:  Maoqing Dong; Zhijun Li; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Journal:  J Biol Chem       Date:  2003-10-30       Impact factor: 5.157

2.  Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism.

Authors:  Marián Castro; Viacheslav O Nikolaev; Dieter Palm; Martin J Lohse; Jean-Pierre Vilardaga
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-18       Impact factor: 11.205

3.  Interaction of synthetic 10-tyrosyl analogues of secretin with hormone receptors on pancreatic acinar cells.

Authors:  J D Gardner; T P Conlon; H C Beyerman; A Van Zon
Journal:  Gastroenterology       Date:  1977-07       Impact factor: 22.682

Review 4.  The structure of secretin family GPCR peptide ligands: implications for receptor pharmacology and drug development.

Authors:  Harriet A Watkins; Maggie Au; Debbie L Hay
Journal:  Drug Discov Today       Date:  2012-05-11       Impact factor: 7.851

5.  Molecular basis for negative regulation of the glucagon receptor.

Authors:  Christopher M Koth; Jeremy M Murray; Susmith Mukund; Azadeh Madjidi; Alexandra Minn; Holly J Clarke; Terence Wong; Vicki Chiang; Elizabeth Luis; Alberto Estevez; Jesus Rondon; Yingnan Zhang; Isidro Hötzel; Bernard B Allan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

8.  Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor.

Authors:  M Dong; Y Wang; E M Hadac; D I Pinon; E Holicky; L J Miller
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

9.  Mutations of aromatic residues in the first transmembrane helix impair signalling by the secretin receptor.

Authors:  E Di Paolo; H Petry; N Moguilevsky; A Bollen; P De Neef; M Waelbroeck; P Robberecht
Journal:  Receptors Channels       Date:  1999

10.  Use of N,O-bis-Fmoc-D-Tyr-ONSu for introduction of an oxidative iodination site into cholecystokinin family peptides.

Authors:  S P Powers; D I Pinon; L J Miller
Journal:  Int J Pept Protein Res       Date:  1988-05
View more
  3 in total

1.  Rational development of a high-affinity secretin receptor antagonist.

Authors:  Maoqing Dong; Kaleeckal G Harikumar; Sweta R Raval; Juliana E Milburn; Carolyn Clark; Rafael Alcala-Torano; Juan C Mobarec; Christopher A Reynolds; Giovanna Ghirlanda; Arthur Christopoulos; Denise Wootten; Patrick M Sexton; Laurence J Miller
Journal:  Biochem Pharmacol       Date:  2020-03-23       Impact factor: 5.858

2.  Structural insight into the activation of a class B G-protein-coupled receptor by peptide hormones in live human cells.

Authors:  Lisa Seidel; Barbara Zarzycka; Saheem A Zaidi; Vsevolod Katritch; Irene Coin
Journal:  Elife       Date:  2017-08-03       Impact factor: 8.140

3.  Extracellular loops 2 and 3 of the calcitonin receptor selectively modify agonist binding and efficacy.

Authors:  Emma Dal Maso; Yue Zhu; Vi Pham; Christopher A Reynolds; Giuseppe Deganutti; Caroline A Hick; Dehua Yang; Arthur Christopoulos; Debbie L Hay; Ming-Wei Wang; Patrick M Sexton; Sebastian G B Furness; Denise Wootten
Journal:  Biochem Pharmacol       Date:  2018-02-16       Impact factor: 5.858

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.